152 related articles for article (PubMed ID: 35877984)
1. Inosine monophosphate dehydrogenase activity and mycophenolate pharmacokinetics in children with nephrotic syndrome treated with mycophenolate mofetil.
Sobiak J; Resztak M; Zachwieja J; Ostalska-Nowicka D
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1197-1208. PubMed ID: 35877984
[TBL] [Abstract][Full Text] [Related]
2. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
[TBL] [Abstract][Full Text] [Related]
3. The Application of Inosine 5'-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome.
Sobiak J; Jóźwiak A; Wziętek H; Zachwieja J; Ostalska-Nowicka D
Pharmaceuticals (Basel); 2020 Aug; 13(8):. PubMed ID: 32824803
[TBL] [Abstract][Full Text] [Related]
4. Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipients.
Fukuda T; Goebel J; Thøgersen H; Maseck D; Cox S; Logan B; Sherbotie J; Seikaly M; Vinks AA
J Clin Pharmacol; 2011 Mar; 51(3):309-20. PubMed ID: 20418509
[TBL] [Abstract][Full Text] [Related]
5. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
[TBL] [Abstract][Full Text] [Related]
6. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
Brunet M; Martorell J; Oppenheimer F; Vilardell J; Millán O; Carrillo M; Rojo I; Corbella J
Transpl Int; 2000; 13 Suppl 1():S301-5. PubMed ID: 11112019
[TBL] [Abstract][Full Text] [Related]
8. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953
[TBL] [Abstract][Full Text] [Related]
9. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.
Li H; Mager DE; Sandmaier BM; Storer BE; Boeckh MJ; Bemer MJ; Phillips BR; Risler LJ; McCune JS
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1121-9. PubMed ID: 24727337
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.
Tang JT; de Winter BC; Hesselink DA; Sombogaard F; Wang LL; van Gelder T
Br J Clin Pharmacol; 2017 Apr; 83(4):812-822. PubMed ID: 27753146
[TBL] [Abstract][Full Text] [Related]
12. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
[TBL] [Abstract][Full Text] [Related]
13. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
[TBL] [Abstract][Full Text] [Related]
14. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters.
Sobiak J; Resztak M; Ostalska-Nowicka D; Zachwieja J; Gąsiorowska K; Piechanowska W; Chrzanowska M
Eur J Pharm Sci; 2015 Sep; 77():189-96. PubMed ID: 26102431
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
[TBL] [Abstract][Full Text] [Related]
17. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
19. The combination of exposure to Tacrolimus, mycophenolic acid, Inosine 5'-Monophosphate Dehydrogenase activity and inhibition in the first week define early histological outcomes in renal transplant recipients.
Thanukrishnan H; Venkataramanan R; Mehta RB; Jorgensen D; Sood P
Clin Transplant; 2022 Dec; 36(12):e14830. PubMed ID: 36177865
[TBL] [Abstract][Full Text] [Related]
20. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]